US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

AVDL Avadel Pharmaceuticals PLC

18.82

0.52 (2.84%)

03 May 2024 - Cerrado

Retrasado por 15 minutos

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Avadel Pharmaceuticals (NASDAQ:AVDL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Avadel Pharmaceuticals.

Avadel Pharmaceuticals (NASDAQ:AVDL)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Avadel Pharmaceuticals.

Noticias sobre Avadel Pharmaceuticals PLC AVDL

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
Miércoles 1 de Mayo 2024 (4 días hace) • GlobeNewswire Inc.

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
Lunes 1 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Martes 5 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Avadel Pharmaceuticals Issues Statement On Patent Litigation
Lunes 4 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Lunes 4 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 4 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
Lunes 26 de Febrero 2024 (2 meses hace) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Avadel Pharmaceuticals PLC Artículos de Noticias

Euro vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones